相关实验视频

Updated: Jun 22, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

用脂质纳米颗粒指导CAR T细胞治疗的过程

Muhammad Babar Khawar^1,2,3, Ali Afzal^4,5, Yue Si^1,2

¹Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou, China.

Journal of nanobiotechnology

|June 29, 2024

概括

脂质纳米颗粒 (LNPs) 提供了一种更安全,更有效的方法来治疗仿真抗原受体 (CAR) T 细胞治疗. 这些先进的传递系统克服了传统的挑战,为改善临床治疗铺平了道路.

科学领域:

生物技术是生物技术.
免疫治疗是一种免疫疗法.
纳米医学是一种纳米医学.

背景情况:

化学抗原受体 (CAR) T细胞疗法显示出希望,但面临挑战.
传统的输送方法可能会导致免疫性和毒性.
脂质纳米粒子 (LNP) 已经成为一种潜在的解决方案.

研究的目的:

探索LNP在CAR T细胞治疗中的优势,与传统方法相比.
突出LNP的多功能性和核酸传递能力.
为解决基于LNP的CAR T细胞治疗的临床考虑.

主要方法:

对LNP介导的CAR T细胞疗法的临床前数据的审查.
对核酸输送的LNP特性进行分析.
讨论临床翻译的挑战和机遇.

主要成果:

与传统方法相比,LNP显示免疫性和毒性降低.
LNP促进了对CAR T细胞工程的基因材料的有效传递.
临床前研究显示出有希望的安全性和有效性.

结论:

在CAR T细胞治疗中,LNP代表了显著的进步.
需要进一步的临床试验来验证基于LNP的方法.
LNP预示着一个更安全,更有效的CAR T细胞治疗的新时代.

关键词:

化学抗原受体的化学抗原受体免疫治疗是一种免疫疗法.脂质纳米颗粒的使用方法非病毒转导的非病毒转导.提供mRNA的交付.

更多相关视频

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Intracranial Cannula Implantation for Serial Locoregional Chimeric Antigen Receptor CAR T Cell Infusions in Mice

Published on: February 24, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.